587 related articles for article (PubMed ID: 34659268)
1. Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination.
Hakroush S; Tampe B
Front Immunol; 2021; 12():762006. PubMed ID: 34659268
[TBL] [Abstract][Full Text] [Related]
2. ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine.
Shakoor MT; Birkenbach MP; Lynch M
Am J Kidney Dis; 2021 Oct; 78(4):611-613. PubMed ID: 34280507
[TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase-antineutrophil cytoplasmic antibody causes different renal diseases by immune-complex formation and pauci-immune mechanism: A case report.
Manabe S; Hatano M; Nakano M; Fujii T; Nitta K; Nagata M
Pathol Int; 2017 Aug; 67(8):419-424. PubMed ID: 28580649
[TBL] [Abstract][Full Text] [Related]
4. De Novo ANCA-Negative Pauci-Immune Crescentic Glomerulonephritis After COVID-19 mRNA Vaccination: A Case Report.
Cho H; Lee HS; Kim SH; Shin J; Hwang JH
J Korean Med Sci; 2023 Oct; 38(41):e341. PubMed ID: 37873632
[TBL] [Abstract][Full Text] [Related]
5. [Case Report: MPO-ANCA Associated Vasculitis After Pfizer-BioNTech COVID-19 mRNA Vaccination].
Mazza F; Cicciarelli A; Rubino F; Leopizzi M; Di Maio V; Cerbelli B; Tatangelo P; Palumbo R; Cioffi EA; Simonelli R
G Ital Nefrol; 2023 Aug; 40(4):. PubMed ID: 37910213
[TBL] [Abstract][Full Text] [Related]
6. Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis.
Hakroush S; Tampe D; Ströbel P; Korsten P; Tampe B
Front Immunol; 2021; 12():737708. PubMed ID: 34759920
[TBL] [Abstract][Full Text] [Related]
7. Complement Components C3 and C4 Indicate Vasculitis Manifestations to Distinct Renal Compartments in ANCA-Associated Glomerulonephritis.
Hakroush S; Tampe D; Korsten P; Ströbel P; Tampe B
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205415
[TBL] [Abstract][Full Text] [Related]
8. Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice.
Hamano Y; Ito F; Suzuki O; Koura M; Matsuoka S; Kobayashi T; Sugitani Y; Wali N; Koyanagi A; Hino O; Suzuki S; Sugamata R; Yoshizawa H; Yumura W; Maruyama N; Kameoka Y; Noda Y; Hasegawa Y; Arai T; Suzuki K
Autoimmunity; 2019; 52(5-6):208-219. PubMed ID: 31476889
[TBL] [Abstract][Full Text] [Related]
9. The influence of cathelicidin LL37 in human anti-neutrophils cytoplasmic antibody (ANCA)-associated vasculitis.
Zhang Y; Shi W; Tang S; Li J; Yin S; Gao X; Wang L; Zou L; Zhao J; Huang Y; Shan L; Gounni AS; Wu Y; Yuan F; Zhang J
Arthritis Res Ther; 2013 Oct; 15(5):R161. PubMed ID: 24286516
[TBL] [Abstract][Full Text] [Related]
10. Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients.
Khalighi MA; Wang S; Henriksen KJ; Bock M; Keswani M; Chang A; Meehan SM
Pediatr Nephrol; 2015 Jun; 30(6):953-9. PubMed ID: 25669759
[TBL] [Abstract][Full Text] [Related]
11. Antineutrophil Cytoplasmic Antibody-associated Vasculitis after COVID-19 Vaccination with Pfizer-BioNTech.
Suzuki M; Sekiguchi Y; Sasaki M; Inaba S; Oyama S; Inoue Y; Warabi M; Ohashi K; Inoshita S
Intern Med; 2022; 61(19):2925-2929. PubMed ID: 36184535
[TBL] [Abstract][Full Text] [Related]
12. ANCA-positive pauci-immune rapidly progressive glomerulonephritis and the nephrotic syndrome.
Jabur WL; Saeed HM
Saudi J Kidney Dis Transpl; 2010 May; 21(3):526-30. PubMed ID: 20427883
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathologic characteristics of pauci-immune anti-myeloperoxidase antibody associated glomerulonephritis with nephrotic range proteinuria.
Xu PC; Chen T; Gao S; Hu SY; Wei L; Yan TK
Ren Fail; 2018 Nov; 40(1):554-560. PubMed ID: 30278797
[TBL] [Abstract][Full Text] [Related]
14. Complement activation in pauci-immune necrotizing and crescentic glomerulonephritis: results of a proteomic analysis.
Sethi S; Zand L; De Vriese AS; Specks U; Vrana JA; Kanwar S; Kurtin P; Theis JD; Angioi A; Cornell L; Fervenza FC
Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i139-i145. PubMed ID: 28391334
[TBL] [Abstract][Full Text] [Related]
15. ANCA-negative pauci-immune crescentic glomerulonephritis.
Chen M; Kallenberg CG; Zhao MH
Nat Rev Nephrol; 2009 Jun; 5(6):313-8. PubMed ID: 19399019
[TBL] [Abstract][Full Text] [Related]
16. Post COVID Vaccination (COVAXIN™ -BB152 V) Pauci-immune Crescentic Glomerulonephritis.
Bansal SB; Rana AS; Manhas N; Rana A
Indian J Nephrol; 2022; 32(5):495-497. PubMed ID: 36568599
[TBL] [Abstract][Full Text] [Related]
17. A Case Report of MPO-ANCA-Associated Vasculitis Following Heterologous mRNA1273 COVID-19 Booster Vaccination.
Kim BC; Kim HS; Han KH; Han SY; Jo HA
J Korean Med Sci; 2022 Jul; 37(26):e204. PubMed ID: 35790206
[TBL] [Abstract][Full Text] [Related]
18. Antineutrophil cytoplasmic antibody-negative pauci-immune crescentic glomerulonephritis associated with rheumatoid arthritis: An unusual case report.
Hsieh HS; Chang CF; Yang AH; Kuo HL; Yang WC; Lin CC
Nephrology (Carlton); 2003 Oct; 8(5):243-7. PubMed ID: 15012711
[TBL] [Abstract][Full Text] [Related]
19. ANCA-associated vasculitis after COVID-19.
Izci Duran T; Turkmen E; Dilek M; Sayarlioglu H; Arik N
Rheumatol Int; 2021 Aug; 41(8):1523-1529. PubMed ID: 34100115
[TBL] [Abstract][Full Text] [Related]
20. Glomerular capillary and endothelial cell injury is associated with the formation of necrotizing and crescentic lesions in crescentic glomerulonephritis.
Fujita E; Nagahama K; Shimizu A; Aoki M; Higo S; Yasuda F; Mii A; Fukui M; Kaneko T; Tsuruoka S
J Nippon Med Sch; 2015; 82(1):27-35. PubMed ID: 25797872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
